Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adekunle Raji

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2007
Human epidermal growth factor receptor 2 testing recommendationAdekunle Raji
Archives of Pathology & Laboratory Medicine|September 11, 2007
Human epidermal growth factor receptor 2 testing recommendationAdekunle Raji, Robert H Lurie
Dialogues in Health|March 22, 2024
"Long walk to 2030": A bibliometric and systematic review of research trends on the UN sustainable development goal 3Saheed Adekunle Raji, Michael Olusegun Demehin
Human Molecular Genetics|September 25, 2007
Somatic acquisition of TGFBR1*6A by epithelial and stromal cells during head and neck and colon cancer developmentYansong Bian, Thomas J Knobloch, Maureen Sadim, et al.
Leukemia Research|July 6, 2004
Phase II trial of arsenic trioxide in relapsed and refractory acute myeloid leukemia, secondary leukemia and/or newly diagnosed patients at least 65 years oldSimrit Parmar, Lynn M Rundhaugen, Larry Boehlke, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Combined analysis of molecular and clinical predictors of gefitinib activity in advanced non-small cell lung cancer: epidermal growth factor receptor mutations do not tell the whole storyAthanassios Argiris, Thomas Hensing, Anjana Yeldandi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2010
Hypoxia-inducible factor-1 {alpha} expression predicts superior survival in patients with diffuse large B-cell lymphoma treated with R-CHOPAndrew M Evens, Laurie H Sehn, Pedro Farinha, et al.
British Journal of Haematology|April 22, 2008
Hypoxia inducible factor-alpha activation in lymphoma and relationship to the thioredoxin familyAndrew M Evens, Paul T Schumacker, Irene B Helenowski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2008
Recommendations for collection and handling of specimens from group breast cancer clinical trialsBrian R Leyland-Jones, Christine B Ambrosone, John Bartlett, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2007
Human epidermal growth factor receptor 2 testing recommendationAdekunle Raji
Archives of Pathology & Laboratory Medicine|September 11, 2007
Human epidermal growth factor receptor 2 testing recommendationAdekunle Raji, Robert H Lurie
Dialogues in Health|March 22, 2024
"Long walk to 2030": A bibliometric and systematic review of research trends on the UN sustainable development goal 3Saheed Adekunle Raji, Michael Olusegun Demehin
Human Molecular Genetics|September 25, 2007
Somatic acquisition of TGFBR1*6A by epithelial and stromal cells during head and neck and colon cancer developmentYansong Bian, Thomas J Knobloch, Maureen Sadim, et al.
Leukemia Research|July 6, 2004
Phase II trial of arsenic trioxide in relapsed and refractory acute myeloid leukemia, secondary leukemia and/or newly diagnosed patients at least 65 years oldSimrit Parmar, Lynn M Rundhaugen, Larry Boehlke, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Combined analysis of molecular and clinical predictors of gefitinib activity in advanced non-small cell lung cancer: epidermal growth factor receptor mutations do not tell the whole storyAthanassios Argiris, Thomas Hensing, Anjana Yeldandi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2010
Hypoxia-inducible factor-1 {alpha} expression predicts superior survival in patients with diffuse large B-cell lymphoma treated with R-CHOPAndrew M Evens, Laurie H Sehn, Pedro Farinha, et al.
British Journal of Haematology|April 22, 2008
Hypoxia inducible factor-alpha activation in lymphoma and relationship to the thioredoxin familyAndrew M Evens, Paul T Schumacker, Irene B Helenowski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2008
Recommendations for collection and handling of specimens from group breast cancer clinical trialsBrian R Leyland-Jones, Christine B Ambrosone, John Bartlett, et al.
Pageof 1